Homma K - Search Results

1

Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.

Homma K, Hayashi K, Kanda T, Yoshioka K, Takamatsu I, Tatematsu S, Kumagai H, Wakino S, Saruta T. Homma K, et al. J Hum Hypertens. 2004 Dec;18(12):879-84. doi: 10.1038/sj.jhh.1001761. J Hum Hypertens. 2004. PMID: 15295613 Clinical Trial.

2

Urinary steroid profile in adrenocortical tumors.

Kikuchi E, Yanaihara H, Nakashima J, Homma K, Ohigashi T, Asakura H, Tachibana M, Shibata H, Saruta T, Murai M. Kikuchi E, et al. Among authors: homma k. Biomed Pharmacother. 2000 Jun;54 Suppl 1:194s-197s. doi: 10.1016/s0753-3322(00)80043-8. Biomed Pharmacother. 2000. PMID: 10915023 Clinical Trial.

3

Impact of calcium antagonists on bleeding time in patients with chronic renal failure.

Hayashi K, Matsuda H, Honda M, Ozawa Y, Tokuyama H, Okubo K, Takamatsu I, Kanda T, Tatematsu S, Homma K, Saruta T. Hayashi K, et al. Among authors: homma k. J Hum Hypertens. 2002 Mar;16(3):199-203. doi: 10.1038/sj.jhh.1001327. J Hum Hypertens. 2002. PMID: 11896510 Clinical Trial.

4

Distinct role of nitric oxide and endothelium-derived hyperpolarizing factor in renal microcirculation. Studies in the isolated perfused hydronephrotic kidney.

Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Kanda T, Homma K, Saruta T. Ozawa Y, et al. Among authors: homma k. Nephron. 2002 Dec;92(4):905-13. doi: 10.1159/000065460. Nephron. 2002. PMID: 12399638

5

Altered renal microvascular response in Zucker obese rats.

Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T. Hayashi K, et al. Among authors: homma k. Metabolism. 2002 Dec;51(12):1553-61. doi: 10.1053/meta.2002.36311. Metabolism. 2002. PMID: 12489067

6

Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.

Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T. Kanda T, et al. Among authors: homma k. Kidney Int. 2003 Dec;64(6):2009-19. doi: 10.1046/j.1523-1755.2003.00300.x. Kidney Int. 2003. PMID: 14633123 Free article.

7

Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.

Hayashi K, Ozawa Y, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Saruta T. Hayashi K, et al. Among authors: homma k. J Cardiovasc Pharmacol. 2003 Dec;42(6):697-702. doi: 10.1097/00005344-200312000-00001. J Cardiovasc Pharmacol. 2003. PMID: 14639089

8

Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.

Matsuda H, Hayashi K, Homma K, Yoshioka K, Kanda T, Takamatsu I, Tatematsu S, Wakino S, Saruta T. Matsuda H, et al. Among authors: homma k. Hypertens Res. 2003 Nov;26(11):875-80. doi: 10.1291/hypres.26.875. Hypertens Res. 2003. PMID: 14714578 Free article. Clinical Trial.

9

Free radical activity depends on underlying vasoconstrictors in renal microcirculation.

Ozawa Y, Hayashi K, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Yoshioka K, Saruta T. Ozawa Y, et al. Among authors: homma k. Clin Exp Hypertens. 2004 Apr;26(3):219-29. doi: 10.1081/ceh-120030231. Clin Exp Hypertens. 2004. PMID: 15132300 Free article.

10

Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.

Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T. Wakino S, et al. Among authors: homma k. Circ Res. 2004 Sep 3;95(5):e45-55. doi: 10.1161/01.RES.0000142313.68389.92. Epub 2004 Aug 12. Circ Res. 2004. PMID: 15308580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters